PBIO's data from Analysis of Cancer Tissue Protein
Post# of 85171
![Avatar](/images/ProfileImages/734810790_1098_wst.png)
OTC PR WIRE Pressure BioSciences, Inc. , a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced the Company’s patented pressure cycling technology (“PCT”) platform was featured as an integral part of a new, innovative workflow for the analysis of proteins from cancer biopsy samples.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)